CClinicalTrials.gg
RecruitingNCT07362797RIGHT-VDLTUpdated Aug 17, 2026

Video-guided Versus Conventional Right-sided Double-Lumen Tubes for One-Lung Ventilation in Thoracoscopic Surgery

An interventional study of Video-guided right-sided double-lumen tube and Conventional right-sided double-lumen tube in Thoracoscopic Surgery, Double Lumen Tube Intubation and One-Lung Ventilation, sponsored by Diansan Su. Recruiting at 3 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Diansan Su · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
566
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This multicentre randomised controlled trial compares a video-guided right-sided double-lumen tube with a conventional right-sided double-lumen tube in adults undergoing elective thoracoscopic surgery requiring one-lung ventilation. The video-guided tube incorporates an integrated camera that provides continuous airway visualisation during initial placement and intraoperative monitoring.

Participants will be randomly assigned in a 1:1 ratio to receive one of the two tubes. Final tube position after initial placement will be confirmed by fibreoptic bronchoscopy in both groups. During one-lung ventilation, additional fibreoptic bronchoscopy will be performed only when clinically indicated or according to predefined rescue criteria.

The primary outcome is successful initial right-sided double-lumen tube placement. Secondary outcomes include right upper-lobe bronchial obstruction, intraoperative tube displacement, hypoxemia during one-lung ventilation, requirement for rescue fibreoptic bronchoscopy, time to satisfactory tube positioning, quality of operative lung collapse, and the number of intraoperative tube repositioning events.

Participants and outcome assessors will remain blinded to treatment allocation, whereas the anaesthesiologist performing intubation cannot be blinded because of the distinct visual and operational characteristics of the two devices. The study aims to determine whether continuous airway visualisation improves the effectiveness and stability of right-sided double-lumen tube management during thoracoscopic surgery.

Read the detailed description

Right-sided double-lumen tubes are used to achieve lung isolation and one-lung ventilation during thoracoscopic surgery. Accurate positioning is particularly important because of the short right main bronchus and the need to maintain patency of the right upper-lobe bronchial opening. Malposition or displacement of a right-sided double-lumen tube may impair right upper-lobe ventilation, compromise lung isolation, and require repeated tube repositioning or fibreoptic bronchoscopy.

This prospective, multicentre, parallel-group randomised controlled trial will enrol 566 adult participants undergoing elective thoracoscopic surgery requiring one-lung ventilation with a right-sided double-lumen tube. Participants will be randomly allocated in a 1:1 ratio to either a video-guided right-sided double-lumen tube or a conventional right-sided double-lumen tube.

In the video-guided group, an integrated visualisation system provides continuous airway visual feedback during initial tube positioning and intraoperative monitoring, allowing real-time identification of changes in tube position. In the conventional group, initial tube placement is performed using standard clinical techniques and anatomical landmarks.

After initial positioning, final tube position will be confirmed by fibreoptic bronchoscopy in both groups. Subsequent fibreoptic bronchoscopy during one-lung ventilation will be performed only when clinically indicated or according to predefined rescue criteria.

The primary outcome is successful initial right-sided double-lumen tube placement, defined as placement of the assigned tube on the first intubation attempt with satisfactory final tube position and satisfactory lung isolation, without withdrawal and reinsertion or exchange to another airway device before initiation of one-lung ventilation.

Secondary outcomes include the incidence of right upper-lobe bronchial obstruction confirmed by fibreoptic bronchoscopy; incidence of intraoperative double-lumen tube displacement; incidence of hypoxemia during one-lung ventilation; requirement for rescue fibreoptic bronchoscopy; time to satisfactory right-sided double-lumen tube positioning; quality of operative lung collapse assessed by the operating surgeon; and the number of intraoperative tube repositioning events.

Participants and outcome assessors will remain blinded to treatment allocation. Because the video-guided and conventional right-sided double-lumen tubes have distinct visual and operational characteristics, the anaesthesiologist performing tracheal intubation and other intraoperative personnel directly involved in airway management cannot be blinded. Outcome assessment will be performed by personnel who are not involved in the airway intervention and remain unaware of treatment allocation.

The trial is designed to determine whether continuous airway visualisation improves initial placement success, maintains more stable right-sided double-lumen tube positioning, reduces the need for subsequent airway interventions, and improves clinically relevant conditions during one-lung ventilation.

02

Conditions studied

  • Thoracoscopic Surgery
  • Double Lumen Tube Intubation
  • One-Lung Ventilation

Keywords

  • Video-guided right-sided double-lumen tube
  • Right-sided double-lumen tube
  • One-lung ventilation
  • Fibreoptic bronchoscopy
  • Thoracoscopic surgery
  • Lung isolation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

**Inclusion Criteria:**

  1. Adults aged 18 years or older.
  2. American Society of Anesthesiologists physical status I-III.
  3. Scheduled for elective thoracoscopic surgery requiring one-lung ventilation with a right-sided double-lumen tube.
  4. Able to provide written informed consent.

**Exclusion Criteria:**

  1. Contraindication to placement of a right-sided double-lumen tube, including a lesion involving the right main bronchus that precludes its use.
  2. Known tracheobronchial anatomical abnormality that may interfere with right-sided double-lumen tube placement or lung isolation.
  3. Known or anticipated difficult airway.
  4. Requirement for rapid-sequence induction.
  5. Emergency surgery.
  6. Severe respiratory instability that, in the investigator's judgement, makes participation unsafe.
  7. Concurrent participation in another interventional clinical trial that could interfere with the present study.
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
566 participants (estimated)

Study arms

  • Experimental
    Video-guided right-sided double-lumen tube

    Participants undergo lung isolation for thoracoscopic surgery using a video-guided right-sided double-lumen tube. The integrated camera provides continuous airway visualisation to facilitate initial positioning and intraoperative detection of tube displacement. Final tube position is confirmed by fibreoptic bronchoscopy after initial positioning. Subsequent fibreoptic bronchoscopy during one-lung ventilation is performed only when clinically indicated or according to predefined rescue criteria.

    Device: Video-guided right-sided double-lumen tube

  • Active comparator
    Conventional right-sided double-lumen tube

    A conventional right-sided double-lumen tube used for lung isolation. Initial placement is performed using standard clinical techniques and anatomical landmarks. Fibreoptic bronchoscopy is used to confirm final tube position after initial positioning and remains available as a rescue technique when clinically indicated.

    Device: Conventional right-sided double-lumen tube

Interventions

  • DeviceVideo-guided right-sided double-lumen tube

    A right-sided double-lumen tube with an integrated visualisation system that provides continuous airway visual feedback during placement and intraoperative monitoring. Fibreoptic bronchoscopy is used to confirm final tube position after initial positioning and remains available as a rescue technique when clinically indicated.

  • DeviceConventional right-sided double-lumen tube

    A conventional right-sided double-lumen tube used for lung isolation. Initial placement is performed using standard clinical techniques and anatomical landmarks. Fibreoptic bronchoscopy is used to confirm final tube position after initial positioning and remains available as a rescue technique when clinically indicated.

05

What researchers measure

Primary outcomes

  1. Successful initial right-sided double-lumen tube placement

    Successful initial placement is defined as placement of the assigned right-sided double-lumen tube on the first intubation attempt, with satisfactory final tube position and satisfactory lung isolation, without withdrawal and reinsertion or exchange to another airway device before initiation of one-lung ventilation.

    Time frame: From initial insertion of the assigned right-sided double-lumen tube until confirmation of satisfactory tube position before initiation of one-lung ventilation (approximately 10 minutes).

Secondary outcomes

  1. Incidence of right upper-lobe bronchial obstruction

    Right upper-lobe bronchial obstruction is defined as partial or complete obstruction of the right upper-lobe bronchial opening by the bronchial lumen or bronchial cuff after initial tube positioning, as confirmed by fibreoptic bronchoscopy. The outcome will be recorded as present or absent.

    Time frame: After initial tube positioning and before initiation of one-lung ventilation (approximately 10 minutes).

  2. Incidence of intraoperative double-lumen tube displacement

    Tube displacement is defined as any intraoperative displacement of the double-lumen tube that requires repositioning to restore satisfactory tube position, ventilation, or lung isolation. The outcome will be recorded as present or absent.

    Time frame: From initiation of one-lung ventilation until completion of one-lung ventilation.

  3. Incidence of hypoxemia during one-lung ventilation

    Hypoxemia is defined as peripheral oxygen saturation (SpO₂) \<90% during one-lung ventilation. The outcome will be recorded as present or absent.

    Time frame: During one-lung ventilation.

  4. Requirement for rescue fibreoptic bronchoscopy

    Rescue fibreoptic bronchoscopy is defined as fibreoptic bronchoscopy performed after initial tube positioning because of suspected tube malposition, inadequate lung isolation, ventilation abnormality, or need for tube repositioning. The outcome will be recorded as present or absent.

    Time frame: From completion of initial tube positioning until completion of one-lung ventilation.

  5. Time to satisfactory right-sided double-lumen tube positioning

    Time from removal of the stylet after the bronchial cuff passes the vocal cords to confirmation of satisfactory right-sided double-lumen tube position. The duration will be recorded in seconds.

    Time frame: During initial tube placement after anaesthesia induction (approximately 10 minutes).

  6. Quality of operative lung collapse

    The operating surgeon, blinded to treatment allocation, will assess operative lung collapse using a three-category scale: excellent (complete collapse with optimal surgical exposure), good (minor residual inflation without interference with surgery), or poor (incomplete collapse interfering with surgical exposure).

    Time frame: 20 minutes after initiation of one-lung ventilation.

  7. Number of intraoperative double-lumen tube repositioning events

    The number of separate tube repositioning procedures required after satisfactory initial placement will be recorded for each participant.

    Time frame: From initiation of one-lung ventilation until completion of one-lung ventilation.

06

Study locations

2 of 3 sites recruiting
  • The First Affiliated Hospital, Zhejiang University School of Medicine,
    Hangzhou, Zhejiang 310000, China
    • Heng Wen · Contact
    Recruiting
  • Affiliated Hospital of Jiaxing University(The First Hospital of Jiaxing)
    Jiaxing, Zhejiang 314000, China
    Recruiting
  • The Second Affiliated Hospital of Jiaxing University(The Second Hospital of Jiaxing)
    Jiaxing, Zhejiang 314000, China
    Not yet recruiting
07

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because of participant privacy considerations and the restrictions of the informed consent and ethics approval.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07362797
Lead sponsor
Diansan Su
Collaborators
First Affiliated Hospital of Zhejiang University, The Second Affiliated Hospital of Jiaxing University, Affiliated Hospital of Jiaxing University
Responsible party
Diansan Su (Chief Physician, Zhejiang University) — Sponsor-investigator
First posted
Jan 23, 2026
Start date
May 30, 2026
Primary completion
Dec 24, 2026 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Aug 17, 2026

Study contacts

Heng Wen
Contact
zyyywenheng@zju.edu.cn
+8615158080827

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion